CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2023; 06(01): 002
DOI: 10.1055/s-0043-1763278
Editorial

Journal of Diabetes and Endocrine Practice (2023): Stepping into the Sixth Year of Age

1   Department of Medicine, Yas Clinic Khalifa City, Khalifa City, Abu Dhabi, United Arab Emirates
2   Department of Medicine, College of Medicine and Health Sciences, Khalifa University, Abu Dhabi, United Arab Emirates
3   Department of Medicine, Dubai Medical College, Dubai, United Arab Emirates
› Institutsangaben
 

    Welcome to 2023. We are pleased that Journal of Diabetes and Endocrine Practice (JDEP) is stepping into its sixth year of age.

    We are starting a new tradition of publishing our annual Gulf Association of Endocrinology and Diabetes (GAED) Medal lecture in the year's first issue. We are very grateful to Prof. Rayaz A. Malik who kindly agreed to take us through his story of challenging the dogma in diabetic neuropathy and beyond by reviewing his work in Scotland, Manchester, and Qatar in a very informative and entertaining manner. The second review in the issue narrates the literature on diabetes and Ramadan in 2022.

    Three original articles are included; all reflect our region's clinical practice. The first article, by Ismael et al, depicts the prevalence of cardiovascular risk factors and associated estimated risk of atherosclerotic cardiovascular disease in adult volunteers in Jeddah, Saudi Arabia. The second article, by the Middle East and North Africa (MENA) Endocrine Research group, is a mixed methods study on physicians' and patients' perceptions and practices of thyroxine replacement therapy during Ramadan fasting. The third article, by Dr. Jamila Elamouri, depicts the incidence and risk factors for developing new-onset diabetes after kidney transplantation in Tripoli, Libya. Finally, a clinical vignette is the week's lesson, telling a near-miss story of a slow-onset type 1 diabetes in a young woman assumed to be type 2 diabetes despite all the warning. She was saved in the nick of time before she crashed into euglycemic diabetic ketoacidosis secondary to the recently added Sodium Glucose Co-Transporter 2 inhibitors.

    As the journal steps into its sixth year, the editorial team feels strongly that it is about time that an application for indexation by Directory of Open Access Journal (DOAJ) and Medline is made. We have shared our opinion with our publisher, hoping they see it our way. We remain indebted to the researchers and key opinion leaders for choosing JDEP to disseminate their research results and share their opinions.


    #

    Conflict of Interest

    None declared.

    Authorship Contribution

    Single author.


    Compliance with Ethical Principles

    No ethical approval is required.



    Address for correspondence

    Salem A. Beshyah, PhD, FRCP
    Department of Medicine, Yas Clinic Khalifa City
    Khalifa City, Abu Dhabi SW11
    UAE   

    Publikationsverlauf

    Artikel online veröffentlicht:
    05. April 2023

    © 2023. Gulf Association of Endocrinology and Diabetes (GAED). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

    Thieme Medical and Scientific Publishers Pvt. Ltd.
    A-12, 2nd Floor, Sector 2, Noida-201301 UP, India